QuidelOrtho Corporation (QDEL) — Fair Value Analysis

Base-case fair value (P50): $7.31 · Current price: $13.67 · Verdict: Overvalued

The Verdict on QDEL

Our latest Monte Carlo simulations suggest that QUIDELORTHO CORP (QDEL) is Fairly Valued, despite its current market price of $13.67 sitting above our median fair value estimate of $7.31. While the model indicates a potential -46.5% downside from the current level to our P50 fair value, this analysis considers QDEL's intrinsic value within a broader range of thousands of forward financial scenarios. The market's current valuation of $13.67 implies a premium compared to our probabilistic median, but the overall assessment remains "Fairly Valued" given the inherent volatility in the simulated outcomes for QDEL.

How QDEL stacks up against peers

Analyzing QDEL through our Monte Carlo framework highlights a quality tier assessment of "weak" regarding its operational and financial health compared to its sector. This classification is a critical input into our fair value calculations, influencing the range of possible outcomes. The disparity between QDEL's $13.67 and the median fair value of $7.31, coupled with the -46.5% gap, suggests the market may be pricing in more optimistic scenarios or future growth drivers than our conservative, probability-weighted model, particularly when considering the "weak" quality tier.

What this means for investors

For investors tracking QDEL, the Fairly Valued verdict, combined with a -46.5% potential downside to our $7.31 estimate, warrants caution. The current price of $13.67 suggests a premium that our Monte Carlo analysis does not fully support as a median outcome. While there are always bull case scenarios, our FairCurve analysis, which incorporates the "weak" quality tier, points to a greater risk profile. Add QDEL to your free FairCurve account to see the full bear/bull distribution and track its fair value as new fundamentals are released.